Orthogonally redundant sensor systems and methods

Patent metadata

Field	Value
Publication number	US-2022087578-A1
Application number	US-202117542655-A
Country	US
Kind code	A1
Filing date	Dec 6, 2021
Priority date	Sep 6, 2011
Publication date	Mar 24, 2022
Grant date	—

Abstract

A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.

First claim

1 - 20 . (canceled)

21 . A glucose monitoring system comprising:
an orthogonally redundant glucose sensor, comprising:
an optical glucose sensor including a light guide on a first substrate and having a proximal portion that is configured to be disposed externally to a body of a user and a distal portion configured for internal placement in the body of the user; and
a non-optical glucose sensor including at least one electrode on a second substrate and having a proximal portion that is configured to be disposed externally to the body of the user and a distal portion configured for internal placement in the body of the user, wherein the first substrate and the second substrate are integrated into an integrated flex circuit, and wherein the light guide is disposed in an interior of the integrated flex circuit and the at least one electrode is disposed on an external surface of the integrated flex circuit.

22 . The glucose monitoring system of claim 21 , wherein the light guide includes a proximal portion that is configured to be disposed externally to the body of the user and a distal portion that is configured for internal placement in the body of the user.

23 . The glucose monitoring system of claim 22 , wherein the proximal portion of the light guide is optically coupled to an assay interrogating system.

24 . The glucose monitoring system of claim 23 , wherein the assay interrogating system is an optoelectronic interrogating system.

25 . The glucose monitoring system of claim 23 , wherein the assay interrogating system is a stacked planar integrated optical system.

26 . The glucose monitoring system of claim 22 , wherein the light guide has a circular cross-section having a diameter of between 200 μm and 500 μm.

27 . The glucose monitoring system of claim 22 , further comprising a glucose-permeable membrane, wherein the glucose-permeable membrane has a closed end, a hollow interior, and an open end coupled to the distal portion of the light guide.

28 . The glucose monitoring system of claim 27 , wherein the optical glucose sensor includes an assay having a glucose receptor, a glucose analog, and a first fluorophore.

29 . The glucose monitoring system of claim 28 , wherein the assay is housed in an assay compartment defined within the hollow interior of the glucose-permeable membrane and between the distal portion of the light guide and the closed end of the glucose-permeable membrane.

30 . The glucose monitoring system of claim 29 , wherein the assay compartment is placed within tissue of the user.

31 . The glucose monitoring system of claim 30 , wherein the glucose-permeable membrane is biodegradable.

32 . The glucose monitoring system of claim 28 , wherein the first fluorophore is water soluble.

33 . The glucose monitoring system of claim 21 , wherein the respective distal portions of the optical sensor and the non-optical sensor are co-located within the body of the user.

34 . The glucose monitoring system of claim 33 , further comprising an insulin pump configured for wireless communication with the optical glucose sensor and the non-optical glucose sensor.

35 . The glucose monitoring system of claim 34 , wherein the glucose monitoring system is a closed-loop system.

36 . The glucose monitoring system of claim 21 , further comprising an insertion device including an insertion needle configured to simultaneously insert the optical glucose sensor and the non-optical glucose sensor into the body of the user.

37 . The glucose monitoring system of claim 21 , wherein the non-optical glucose sensor is an electrochemical glucose sensor.

38 . The glucose monitoring system of claim 37 , wherein the electrochemical glucose sensor includes a plurality of electrodes.

39 . The glucose monitoring system of claim 21 , further comprising an insertion device including an insertion needle, wherein the integrated flex circuit is configured to be carried inside the needle for simultaneous insertion of the optical glucose sensor and the non-optical glucose sensor into the body of the user.

Assignees

• Medtronic Minimed Inc

Inventors

• Shah Rajiv
• Kristensen Jesper Svenning
• Wolfe Katherine T
• Aasmul Soren
• Bansal Anubhuti

Classifications

• G01N33/66

  involving blood sugars, e.g. galactose · CPC title

• A61B5/14532 Primary

  for measuring glucose, e.g. by tissue impedance measurement · CPC title

• A61B5/1459

  invasive, e.g. introduced into the body by a catheter · CPC title

• A61B5/742

  using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339) · CPC title

• G01N2021/7759

  Dipstick; Test strip · CPC title